Hillstream BioPharma Inc. (HILS)
NASDAQ: HILS
· Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM
Hillstream BioPharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Cash & Equivalents | 2.69M | 3.9M | 3.57M | 6.51M | 7.6M | 9.48M | 11.12M | 4.36K | 45.09K | 29.27K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 477.89K | 695.38K | 1.15M | 178.09K | 235.95K | 301.37K | 233.18K | 617.32K | 3.87K | 5.05K |
Total Current Assets | 3.17M | 4.6M | 4.72M | 6.69M | 7.83M | 9.79M | 11.36M | 621.68K | 414.89K | 283.13K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Assets | 3.17M | 4.6M | 4.72M | 6.69M | 7.83M | 9.79M | 11.36M | 621.68K | 414.89K | 283.13K |
Account Payables | 1.14M | 1.14M | 718.99K | 954.5K | 536.84K | 559.53K | 597.46K | 1.46M | 1.21M | 1.04M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 697.84K | 658.43K | 463.6K |
Short-Term Debt | n/a | n/a | 559.92K | n/a | n/a | n/a | n/a | 1.39M | 1.22M | 646.48K |
Other Current Liabilities | 271.33K | 389.92K | 242.22K | 190.47K | 179.87K | 185.94K | 418.88K | 1.68M | 3.53M | 3.07M |
Total Current Liabilities | 1.41M | 1.53M | 1.52M | 1.14M | 716.71K | 745.47K | 1.02M | 4.53M | 6.63M | 5.22M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 772.9K | 933.36K | 1.36M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | 718.99K | 954.5K | 536.84K | n/a | n/a | 772.9K | 933.36K | 1.36M |
Total Liabilities | 1.41M | 1.53M | 1.52M | 1.14M | 716.71K | 745.47K | 1.02M | 5.31M | 7.56M | 6.58M |
Total Debt | n/a | n/a | 559.92K | n/a | n/a | n/a | n/a | 2.17M | 2.15M | 2.01M |
Common Stock | 1.76K | 1.69K | 1.16K | 1.16K | 1.16K | 1.16K | 1.14K | 636.00 | 636.00 | 636.00 |
Retained Earnings | -22.23M | -20.41M | -18.07M | -15.38M | -13.62M | -11.49M | -9.85M | -6.91M | -9.36M | -8.51M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 1.76M | 3.07M | 3.2M | 5.54M | 7.12M | 9.04M | 10.34M | -4.68M | -7.14M | -6.3M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |